Literature DB >> 1666184

Reassessment of plasma angiotensins measurement: effects of protease inhibitors and sample handling procedures.

K Kohara1, Y Tabuchi, P Senanayake, K B Brosnihan, C M Ferrario.   

Abstract

Characterization of C- and N-terminal forms of angiotensin (Ang) peptides mandated assessment of methods to determine plasma levels. 125I-Ang I, 125I-Ang II, and 125I-Ang(1-7) were added to blood samples in the presence of protease inhibitors. Ethylenediaminetetraacetic acid (EDTA) inhibited the conversion of 125I-Ang I to 125I-Ang II. o-Phenanthroline and EDTA (EDTA + o-Ph) did not eliminate [des-Asp1] fragments or 125I-Ang(1-7). The combination of EDTA + o-Ph and pepstatin A or 4-(chloromercuri) benzoic acid (PCMB) significantly reduced 125I-Ang(1-7) generation. Only PCMB plus EDTA + o-Ph eliminated [des-Asp1] fragments. Authentic plasma values of Ang peptides require the correct choice of protease inhibitors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1666184     DOI: 10.1016/0196-9781(91)90070-6

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  26 in total

1.  Simultaneous analysis of angiotensin peptides by LC-MS and LC-MS/MS: metabolism by bovine adrenal endothelial cells.

Authors:  Lijie Cui; Kasem Nithipatikom; William B Campbell
Journal:  Anal Biochem       Date:  2007-07-05       Impact factor: 3.365

Review 2.  Biochemical evaluation of the renin-angiotensin system: the good, bad, and absolute?

Authors:  Mark C Chappell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-10-16       Impact factor: 4.733

3.  Altered systemic hemodynamic and baroreflex response to angiotensin II in postural tachycardia syndrome.

Authors:  Hossam I Mustafa; Satish R Raj; André Diedrich; Bonnie K Black; Sachin Y Paranjape; William D Dupont; Gordon H Williams; Italo Biaggioni; David Robertson
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-01-13

4.  Longitudinal study of angiotensin peptides in normal and pre-eclamptic pregnancy.

Authors:  K Bridget Brosnihan; David C Merrill; Liliya M Yamaleyeva; Kai Chen; Liomar Neves; JaNae Joyner; Courtney Givner; Kristy Lanier; Cheryl Moorefield; Brian Westwood
Journal:  Endocrine       Date:  2020-04-22       Impact factor: 3.633

5.  Antenatal betamethasone exposure alters renal responses to angiotensin-(1-7) in uninephrectomized adult male sheep.

Authors:  Jianli Bi; Stephen A Contag; Luke C Carey; Lijun Tang; Nancy K Valego; Mark C Chappell; James C Rose
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2012-11-16       Impact factor: 1.636

6.  Abnormalities of angiotensin regulation in postural tachycardia syndrome.

Authors:  Hossam I Mustafa; Emily M Garland; Italo Biaggioni; Bonnie K Black; William D Dupont; David Robertson; Satish R Raj
Journal:  Heart Rhythm       Date:  2011-01-22       Impact factor: 6.343

7.  Hemodynamic and hormonal patterns of untreated essential hypertension in men and women.

Authors:  Carlos M Ferrario; Jewell A Jessup; Ronald D Smith
Journal:  Ther Adv Cardiovasc Dis       Date:  2013-11-26

8.  Hemodynamic, morphometric and autonomic patterns in hypertensive rats - Renin-Angiotensin system modulation.

Authors:  Fernanda S Zamo; Silvia Lacchini; Cristiano Mostarda; Silvana Chiavegatto; Ivana C M Silva; Edilamar Menezes Oliveira; Maria Claudia Irigoyen
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

9.  Decreased cardiac Ang-(1-7) is associated with salt-induced cardiac remodeling and dysfunction.

Authors:  Jasmina Varagic; Sarfaraz Ahmad; K Bridget Brosnihan; Leanne Groban; Mark C Chappell; E Ann Tallant; Patricia E Gallagher; Carlos M Ferrario
Journal:  Ther Adv Cardiovasc Dis       Date:  2009-11-27

10.  Phase I and pharmacokinetic study of angiotensin-(1-7), an endogenous antiangiogenic hormone.

Authors:  W Jeffrey Petty; Antonius A Miller; Thomas P McCoy; Patricia E Gallagher; E Ann Tallant; Frank M Torti
Journal:  Clin Cancer Res       Date:  2009-11-17       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.